Keratoconjunctivitis, Vernal
National Organization for Rare Disorders, Inc.
Synonyms
- Seasonal Conjunctivitis
- Spring Ophthalmia
- VKC
Disorder Subdivisions
General Discussion
Vernal keratoconjunctivitis is a non-contagious, seasonal allergic disorder usually appearing during the spring or warm weather. Major symptoms include hard, cobblestone-like bumps (papillae) on the upper eyelid, stringy or mucous discharge, inflammation of the mucous membrane lining the inside of the eyelid (conjunctiva) and the tough, white, outer coat of the eyeball (sclera), sensitivity to light and intense itching. .
Symptoms
Vernal keratoconjunctivitis symptoms include inflammation of the outer membrane of the eye. This causes the eyes to become red and may cause blurred vision. The eyes become sensitive to light and itch intensely. Usually both eyes are affected, and cobblestone-like changes appear in the upper eyelid linings (palpebral conjunctiva). In other cases, a gelatinous nodule may develop in the tissue adjacent to the cornea (limbus). In very severe cases, the corneas may scar (shield ulcers) leading to temporarily or permanently reduced vision. .
Causes
The cause of Vernal Keratonconjunctivitis is a hypersensitivity or allergic reaction of the eyes to airborne allergens.
Affected Populations
Onset of vernal keratoconjunctivitis typically occurs between ages 3 and 25 years. The disorder appears to affect more males than females. It occurs most often during the spring or summer. .
Related Disorders
Symptoms of the following disorder can be similar to those of vernal keratoconjunctivitis. Comparisons may be useful for a differential diagnosis.
Conjunctivitis or "pink eye" is caused by an infection of the outer lining of the eye and eyelids from bacteria or viruses. The eyes become red and irritated with a sandy or burning feeling. The disease may follow a cold or sore throat, and is most common in children. Sticky pus is visible in the eye and can cause the eyelids to stick together. Pink eye is highly contagious.
Standard Therapies
Treatment of vernal keratoconjunctivitis is symptomatic and supportive. If the agent that causes the allergy is identified, it should, of course, be avoided if possible. Cold compresses and artifical tears and ointments soothe, lubricate and dilute the antigen. Topical antihistamines producing constriction of the blood vessels and ducts may help. Mast-cell stabilizers may be useful before a flare-up of the disorder or may help control a flare-up, but do little to reduce the symptoms of VKC. Non-steroid anti-inflammatories (NSAIDS) may relieve symptoms in moderate cases but topical steroids should be reserved for more severe cases.
The orphan product lodoxamide tromethamine (Alomide Ophthalmic Solution) has been approved for treatment of vernal keratoconjunctivitis. The product is manufactured by:
Alcon Laboratories 6201 South Freeway Ft. Worth, TX 76134
The drug cromolyn sodium is now being used in the treatment of ocular allergies such as vernal keratoconjunctivitis, as well. The orphan drug Levocabastine has also been approved by the FDA for the treatment of this disorder. For more information on this drug, physicians may contact:
Iolab Pharmaceuticals 500 Iolab Drive Claremont, CA 91711 .
References
Beers MH, Berkow R, eds. The Merck Manual, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999:714-16, 1050.
Berkow R., ed. The Merck Manual-Home Edition. Whitehouse Station, NJ: Merck Research Laboratories; 1997:826-27.
Larson DE, ed. Mayo Clinic Family Health Book. New York, NY: William Morrow and Company, Inc; 1996:542-43.
REVIEW ARTICLES Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 2003;43:41-58.
Bielory L, Mongia A. Current Opinion of immunotherapy for ocular allergy. Curr Opin Allergy Clin Immunol. 2002;2:447-52.
Bielory L Kempuraj D, Theoharides T. Topical immunopharmacology of ocular allergies. Curr Opin Allergy Clin Immunol. 2002;2:435-45.
Trocme SD, Sra KK. Spectrum of ocular allergy. Curr Opin Allergy Clin Immunol. 2002;2:423-27.
Friedlander MH. Conjunctival provocation testing: overview of recent clinical trials in ocular allergy.. Curr Opin Allergy Clin Immunol. 2002;2:413-17.
FROM THE INTERNET M-Eye Conditions. University of Michigan, Kellogg Eye Center. Vernal Keratoconjunctivitis. nd. 2pp www.kellogg.umich.eu/conditions/allergies/vernal.html
EyeMDLink. Vernal Keratoconjunctivitis. 2002:2pp. www.eyemdlink.com/Conditionasp?conditionID=450
Auckland Allergy Clinic. Allergic Conjunctivitis. nd. 6pp. www.allergyclinic.co.nz/guides/9.html
Schmid KL, Swann PG. Vernal Keratoconjunctivitis: Signs, symptoms and therapeutic management. Ot. February 23, 2001:3pp. www.optometry.co.uk
Handbook of Ocular Disease Management. Vernal keratoconjunctivitis (VKC). nd. 2pp. www.revoptom.com/handbook/oct02_sec2_3.htm
Handbook of Ocular Disease Management. Allergic conjunctivitis & Vernal Keratocon-junctivitis (VKC). nd. 3pp. www.revoptom.com/handbook/SECT2A.HTM
Resources
NIH/National Eye Institute
Building 31 Rm 6A32 31 Center Dr MSC 2510 Bethesda, MD 20892-2510 United States Tel: 3014965248 Fax: 3014021065 Email: 2020@nei.nih.gov Internet: http://www.nei.nih.gov/
NIH/National Institute of Allergy and Infectious Diseases
6610 Rockledge Drive MSC 6612 Bethesda, MD 20892-6612 Tel: (301)496-5717 Fax: (301)402-3573 TDD: (800)877-8339 Internet: http://www.niaid.nih.gov/
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for
informational purposes only. NORD recommends that affected individuals seek the advice or counsel of
their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms
listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the
topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease
Database completely current and accurate. Please check with the agencies listed in the Resources section
for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization
for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site
www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 3/18/2003
Copyright 1988, 1989, 1994, 2003
National Organization for Rare Disorders, Inc.
|
|
|
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|